Shu‐Ching Chang - Concepedia

Author

Shu‐Ching Chang

Also Known As

Chang, S.C., Chang, Shu-Ching, S Chang, S. Chang, S.-C. Chang, S.C. Chang, Shu Chang, Shu Ching Chang, Shu- Ching Chang, Shu-Ching Chang

211

Publications

6.4K

Citations

H-Index

153

Concepts

All Affiliations

3M (United States)St. Joseph Health System Providence College Saint John's Health Center Providence Portland Medical Center

About

Shu‐Ching Chang is an author at 3M (United States) specializing in medicine, pharmacology, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	43	3.6K
2	Health Sciences	11	12	713
3	Business	2	2	111
4	Education	1	1	98
5	Management	1	1	98

Shu‐Ching Chang

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors Thomas Duhen, Rebekka Duhen, Ryan Montler, Nature Communications	2018	903
A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans Geary W. Olsen, Shu‐Ching Chang, Patricia E. Noker, Toxicology Pharmacological StudyPhysiologyPharmacologyToxicologyPharmacotherapy	2008	332
Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals David J. Ehresman, John W. Froehlich, Geary W. Olsen, Environmental Research Human Whole BloodSerum MatricesMedicineBioanalysisFluorous Synthesis	2006	330
Perfluoroalkyl Acids and Related Chemistries—Toxicokinetics and Modes of Action Melvin E. Andersen, John L. Butenhoff, Shu‐Ching Chang, Toxicological Sciences Organic ChemistryChemistryComparative ToxicologyToxicological MechanismEnvironmental Chemistry	2007	318
Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS) Shu‐Ching Chang, Julie Thibodeaux, Mary L. Eastvold, Toxicology Thyroid Hormone StatusPituitary FunctionEndocrine MechanismMedicinePhysiology	2007	203
Comparative pharmacokinetics of perfluorohexanesulfonate (PFHxS) in rats, mice, and monkeys Maria Sundström, Shu‐Ching Chang, Patricia E. Noker, Reproductive Toxicology Pharmacological StudyOxidative StressPharmacologyToxicologyPharmacotherapy	2011	170
Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys Shu‐Ching Chang, Patricia E. Noker, Gregory S. Gorman, Reproductive Toxicology Pharmacological StudyPharmacologyToxicologyPharmacotherapyExperimental Pharmacology	2011	162
Perfluoroalkyl Sulfonates Cause Alkyl Chain Length–Dependent Hepatic Steatosis and Hypolipidemia Mainly by Impairing Lipoprotein Production in APOE*3-Leiden CETP Mice Silvia Bijland, Patrick C.N. Rensen, Elsbet Pieterman, Toxicological Sciences	2011	159
A temporal trend study (1972–2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm, Sweden Maria Sundström, David J. Ehresman, Anders Bignert, Environment International Food ContaminantToxicologyChemical ContaminantTemporal Trend StudyFood Safety	2010	151
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells Rebekka Duhen, Carmen Ballesteros‐Merino, Alexandra K. Frye, Nature Communications Neoadjuvant TherapyImmunologyImmunoeditingPathologyImmunotherapeutics	2021	150

Page 1